TrademarkDir
DOME THERAPEUTICS
LIVE

Serial Number

97260713

Owner

Dome Therapeutics

First Use Date

Jan 1, 2020

Filing Date

Feb 9, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DOME THERAPEUTICS Trademark

Serial Number: 97260713 • Registration: 7409302

DOME THERAPEUTICS is a trademark filed by Dome Therapeutics on February 9, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Dome Therapeutics (2 trademarks)

10926 White Dahlia Drive
Woodstock, MD 21163

Entity Type: 16

Trademark Details

Filing Date

February 9, 2022

Registration Date

June 4, 2024

First Use Anywhere

January 1, 2020

First Use in Commerce

June 1, 2020

Published for Opposition

December 27, 2022

Goods & Services

Biotechnology research; research and development in the pharmaceutical and biotechnology fields; providing information on the subject of scientific research in the field of biochemistry and biotechnology

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 4, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 4, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 26, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 26, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 26, 2024 SUPC
SOU EXTENSION 2 GRANTED
Apr 26, 2024 EX2G
USE AMENDMENT FILED
Apr 25, 2024 IUAF
ASSIGNED TO EXAMINER
Apr 25, 2024 DOCK
NOTICE OF REVIVAL - E-MAILED
Apr 25, 2024 NREV
TEAS STATEMENT OF USE RECEIVED
Apr 25, 2024 EISU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Apr 25, 2024 TPEX
PETITION TO REVIVE-GRANTED
Apr 25, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 25, 2024 PROA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 25, 2024 AITU
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 25, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 24, 2024 ABN6
SOU EXTENSION 2 FILED
Feb 21, 2024 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 17, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 16, 2024 EX1G
ASSIGNED TO EXAMINER
Jan 3, 2024 DOCK
NOTICE OF REVIVAL - E-MAILED
Jan 3, 2024 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 2, 2024 TPEX
PETITION TO REVIVE-GRANTED
Jan 2, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 2, 2024 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 2, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 2, 2023 ABN6
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 29, 2023 AITU
LATE FILED STATEMENT OF USE
Aug 22, 2023 LSOU
TEAS STATEMENT OF USE RECEIVED
Aug 22, 2023 EISU
SOU EXTENSION 1 FILED
Aug 21, 2023 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 7, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 22, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 22, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 22, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 22, 2022 CNEA
ASSIGNED TO EXAMINER
Nov 21, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2022 NWOS
NEW APPLICATION ENTERED
Feb 12, 2022 NWAP

Related Trademarks

More from this Owner

DOME THERAPEUTICS

DOME THERAPEUTICS